
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Search Results : Heart failure (Losartan potassium - Heart failure)
Records returned : 29 (on 29 May 2025 at 11:08:28).
Return to search results for ' Heart failure '.
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred angiotensin II receptor blocker.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Green
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
ONE 62.5microgram tablet is approximately equivalent to 50microgram (1mL) elixir
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Only licensed for use in children.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Important
2mg, 4mg and 8mg tablets. Do not prescribe as perindopril arginine.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Preferred
Spironolactone is the preferred aldosterone antagonist for all stages of heart failure.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation restricted to cardiology. Transfer to primary care only after initiation and at least the first month supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Transfer of prescribing to primary care only after initiation and stabilisation by the specialist.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to initiation by cardiology only. Transfer of prescribing to primary care only after initiation and at least the first month supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation by specialist.
The licensed (Xaqua) and unlicensed (Zaroxolyn) tablets have different bioavailabilities. These products are not interchangable=Prescribe by Brand
Formulary Status :
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribing in primary care on specialist recommendation.
Formulary Status :
Links :
Indication :
Status :
Amber
Formulations :
- Tablets
Restrictions / Comments:
Important
Do not co-administer with an ACEi or ARB due to risk of angioedema.
Formulary Status :
Links :
Indication :
Status :
Non Formulary
Formulations :
- Granules
Restrictions / Comments:
Important
Do not co-administer with an ACEi or ARB due to risk of angioedema.
Only licensed for use in children.
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Important
Off label. Acutely decompensated heart failure. RSCH Cardiology only
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Acutely decompensated heart failure. Unlicensed. Restricted to cardiology / ICU only. Use according to protocol
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted use:
ITU only at SASH
Consultants only at RSCH
Formulary Status :
Links :